Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
Hepatitis B Virus
54%
Recurrent Disease
33%
Chronic Hepatitis B
28%
Neoplasm
20%
Membrane Antigen
18%
Carcinogenesis
17%
Inflammation
15%
Liver Carcinogenesis
12%
Transgenic Mouse
12%
Gastrointestinal Stromal Tumor
11%
Lung Hemorrhage
11%
Systemic Lupus Erythematosus
11%
Antiviral Drug
11%
Hepatitis B
11%
Antiviral Therapy
11%
Liver Injury
9%
Alanine Aminotransferase
9%
Virus DNA
9%
Entecavir
8%
Tumor Growth
8%
Overall Survival
7%
Hepatitis B Antigen
7%
Cancer Growth Factor
6%
Hepatitis B Virus X Protein
6%
Liver Cancer
6%
Circular DNA
6%
Virus Carcinogenesis
6%
Disease Exacerbation
6%
Cell Viability
6%
Malignant Neoplasm
6%
Liver Tumor
5%
Immunoglobulin
5%
Immunoglobulin G
5%
Neuroendocrine Tumor
5%
Cell Cycle Protein
5%
Lupoid Hepatitis
5%
Bladder Cancer
5%
Hodgkin Disease
5%
Nucleophosmin
5%
Abdominal Aortic Aneurysm
5%
Long Untranslated RNA
5%
Doxorubicin
5%
Eosinophilic Granuloma
5%
Wegener Granulomatosis
5%
Janus Kinase
5%
Microsphere
5%
Chronic Inflammation
5%
Tumor Recurrence
5%
Cisplatin
5%
Medicine and Dentistry
Hepatocellular Carcinoma
78%
Recurrent Disease
25%
Transitional Cell Carcinoma
24%
Hepatitis B Virus
24%
Neoplasm
19%
Hepatocyte
15%
Hepatectomy
14%
Biological Marker
13%
Carcinogenesis
13%
Bladder
11%
Pediatrics
11%
Virus
11%
Liver Tumor
10%
Cancer
10%
Liver Cancer
9%
Chronic Hepatitis B
9%
Liver Tissue
8%
Overall Survival
8%
Upper Urinary Tract
8%
Infarction
7%
Embolization
7%
Liver Fibrosis
7%
Bleeding
6%
Liver Histology
6%
Carcinoma Cell
6%
Cancer Growth Factor
6%
Hepatitis B Virus X Protein
6%
Sclerosing Cholangitis
5%
Atezolizumab
5%
Neuroendocrine Tumor
5%
Tongue
5%
Liver Regeneration
5%
Osteopontin
5%
Cell Cycle Protein
5%
Cholangiocarcinoma
5%
Colorectal Carcinoma
5%
Electromagnetic Field
5%
Lupoid Hepatitis
5%
Fibroblast Growth Factor Receptor 1
5%
Partial Hepatectomy
5%
Gastrointestinal Stromal Tumor
5%
Autoimmune Liver Disease
5%
Abdominal Aortic Aneurysm
5%
Germinal Center
5%
Inflammatory Cell
5%
Macrophage
5%
Microsphere
5%
Progesterone Receptor
5%
Protein Expression
5%
Membrane Component
5%
Keyphrases
Liver
14%
Hepatitis B Virus
13%
Hepatocellular Carcinoma
12%
Electromagnetic Thermotherapy
11%
Pre-S2 mutant
9%
Ground Glass Hepatocytes
8%
Liver Tissue
7%
Fine-needle
7%
Metastasis
7%
PreS2
7%
Pre-S mutants
6%
Tumorigenesis
6%
Hepatocellular Carcinoma Recurrence
6%
Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
5%
RMI2
5%
Checkpoint Inhibitors
5%
CD44 Expression
5%
Atezolizumab
5%
Immune-related Adverse Reactions
5%
Cluster of Differentiation 44 (CD44)
5%
Primary Sclerosing Cholangitis
5%
Cardiovascular Survival
5%
Electromagnetic-thermal
5%
Human Cancer
5%
Cell Cycle Proteins
5%
Cholangiocarcinoma
5%
Thermal Surgery
5%
Hepatoblastoma
5%
HBV e Antigen
5%
Early Recurrence
5%
Glycan Analysis
5%
Domain Generalization
5%
Autoimmune Liver Disease
5%
Feature Disentanglement
5%
Nucleophosmin 1 (NPM1)
5%
NASH-related HCC
5%
NEIL3
5%
Plasma Proteomics
5%
Hepatobiliary Carcinoma
5%
Pediatric Hepatocellular Carcinoma
5%
N-glycoprofiling
5%
Trophoblastic Differentiation
5%
PTP4A3
5%
Antigen Production
5%
Cardiac Amyloidosis
5%
Epstein-Barr Virus
5%
Renal Ischemia
5%
Anti-B Cell Therapy
5%
Granulomatosis with Polyangiitis
5%
Tumor-associated Macrophages
5%
